999久久久国产精品,亚洲精品无码一区二区卧室 ,亚洲精品久久久蜜桃,免费观看的国产大片app下载

美國Nabi Biopharmaceuticals       
美國Nabi生物制藥公司研發(fā)的一種用于治療尼古丁成癮和預防復吸疫苗NieVax（尼古丁接合疫苗）獲得FDA授予的快通道審批地位。該疫苗將在第二季度進入Ⅱ期概念驗證臨床試驗階段，包括300位患者，試驗結果將于2007年下半年得出。在未來幾年里，戒煙市場將發(fā)生明顯變化。
PentaStaph （五金黃色葡萄球菌疫苗）

Nabi Biopharmaceuticals is focused on developing a series of first and second generation products that address unmet medical needs and offer opportunities in our core business areas: nicotine addiction and gram-positive bacterial infections.

Driven by our clinical development programs, we are focused on building value and are seeking partners for our vaccine programs: NicVAX? (Nicotine Conjugate Vaccine) and PentaStaph? (Staphylococcal Polysaccharide Conjugate and Toxoid Vaccine). Our headquarters is located in Rockville, Maryland along with our Research and Development facility.